263 related articles for article (PubMed ID: 19342973)
1. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
[TBL] [Abstract][Full Text] [Related]
2. Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells.
Tamada K; Harada M; Abe K; Li T; Tada H; Onoe Y; Nomoto K
Cancer Immunol Immunother; 1998 May; 46(3):128-36. PubMed ID: 9625536
[TBL] [Abstract][Full Text] [Related]
3. Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA.
Teramoto K; Kontani K; Fujita T; Ozaki Y; Sawai S; Tezuka N; Fujino S; Itoh Y; Taguchi O; Kannagi R; Ogasawara K
Cancer Immunol Immunother; 2007 Mar; 56(3):331-42. PubMed ID: 16896967
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity.
Yamaguchi S; Tatsumi T; Takehara T; Sasakawa A; Hikita H; Kohga K; Uemura A; Sakamori R; Ohkawa K; Hayashi N
Cancer Immunol Immunother; 2008 Dec; 57(12):1861-9. PubMed ID: 18438665
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.
Gholizadeh Z; Tavakkol-Afshari J; Nikpoor AR; Jalali SA; Jaafari MR
J Cell Mol Med; 2018 Jan; 22(1):558-567. PubMed ID: 28944998
[TBL] [Abstract][Full Text] [Related]
6. Antigen presenting B cells facilitate CD4 T cell cooperation resulting in enhanced generation of effector and memory CD4 T cells.
Kroeger DR; Rudulier CD; Bretscher PA
PLoS One; 2013; 8(10):e77346. PubMed ID: 24155947
[TBL] [Abstract][Full Text] [Related]
7. Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
Hotblack A; Seshadri S; Zhang L; Hamrang-Yousefi S; Chakraverty R; Escors D; Bennett CL
Mol Ther; 2017 Feb; 25(2):504-511. PubMed ID: 28153097
[TBL] [Abstract][Full Text] [Related]
8. Current State of Dendritic Cell-Based Immunotherapy: Opportunities for
Huber A; Dammeijer F; Aerts JGJV; Vroman H
Front Immunol; 2018; 9():2804. PubMed ID: 30559743
[TBL] [Abstract][Full Text] [Related]
9. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.
Ingulli E; Mondino A; Khoruts A; Jenkins MK
J Exp Med; 1997 Jun; 185(12):2133-41. PubMed ID: 9182685
[TBL] [Abstract][Full Text] [Related]
10. Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.
Hüttner KG; Breuer SK; Paul P; Majdic O; Heitger A; Felzmann T
Cancer Immunol Immunother; 2005 Jan; 54(1):67-77. PubMed ID: 15693141
[TBL] [Abstract][Full Text] [Related]
11. Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node.
Smith AL; Fazekas de St Groth B
J Exp Med; 1999 Feb; 189(3):593-8. PubMed ID: 9927521
[TBL] [Abstract][Full Text] [Related]
12. A tissue-like platform for studying engineered quiescent human T-cells' interactions with dendritic cells.
Abu-Shah E; Demetriou P; Bálint Š; Mayya V; Kutuzov MA; Dushek O; Dustin ML
Elife; 2019 Sep; 8():. PubMed ID: 31552826
[TBL] [Abstract][Full Text] [Related]
13. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.
Dhodapkar MV; Steinman RM; Sapp M; Desai H; Fossella C; Krasovsky J; Donahoe SM; Dunbar PR; Cerundolo V; Nixon DF; Bhardwaj N
J Clin Invest; 1999 Jul; 104(2):173-80. PubMed ID: 10411546
[TBL] [Abstract][Full Text] [Related]
14. Necroptotic-susceptible dendritic cells exhibit enhanced antitumor activities in mice.
Zhao Z; Zhang G; Sun Y; Winoto A
Immun Inflamm Dis; 2020 Sep; 8(3):468-479. PubMed ID: 32663380
[TBL] [Abstract][Full Text] [Related]
15. Chaperone-rich cell lysates, immune activation and tumor vaccination.
Zeng Y; Graner MW; Katsanis E
Cancer Immunol Immunother; 2006 Mar; 55(3):329-38. PubMed ID: 15887013
[TBL] [Abstract][Full Text] [Related]
16. Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo.
Wahlund CJE; Güclüler G; Hiltbrunner S; Veerman RE; Näslund TI; Gabrielsson S
Sci Rep; 2017 Dec; 7(1):17095. PubMed ID: 29213052
[TBL] [Abstract][Full Text] [Related]
17. cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1.
Ferris ST; Ohara RA; Ou F; Wu R; Huang X; Kim S; Chen J; Liu TT; Schreiber RD; Murphy TL; Murphy KM
Cancer Immunol Res; 2022 Aug; 10(8):920-931. PubMed ID: 35648641
[TBL] [Abstract][Full Text] [Related]
18. Combinational Pulsing of TAAs Enforces Dendritic Cell-Based Immunotherapy through T-Cell Proliferation and Interferon-γ Secretion in LLC1 Mouse Model.
Lee JU; Kim SH; Lee SH; Ji MJ; Jin JA; So HJ; Song ML; Lee HK; Kang TW
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254898
[TBL] [Abstract][Full Text] [Related]
19. Antigen Self-Presented Personalized Nanovaccines Boost the Immunotherapy of Highly Invasive and Metastatic Tumors.
Wang T; Han M; Han Y; Jiang Z; Zheng Q; Zhang H; Li Z
ACS Nano; 2024 Feb; 18(8):6333-6347. PubMed ID: 38349234
[TBL] [Abstract][Full Text] [Related]
20. Antigen-Specific Stimulation of CD8
Hong E; Dobrovolskaia MA
Methods Mol Biol; 2024; 2789():171-184. PubMed ID: 38507003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
